Long-Term Performance of an Image-Based Short-Term Risk Model for Breast Cancer.
Journal
Journal of clinical oncology : official journal of the American Society of Clinical Oncology
ISSN: 1527-7755
Titre abrégé: J Clin Oncol
Pays: United States
ID NLM: 8309333
Informations de publication
Date de publication:
10 05 2023
10 05 2023
Historique:
medline:
8
5
2023
pubmed:
18
3
2023
entrez:
17
3
2023
Statut:
ppublish
Résumé
Image-derived artificial intelligence-based short-term risk models for breast cancer have shown high discriminatory performance compared with traditional lifestyle/familial-based risk models. The long-term performance of image-derived risk models has not been investigated. We performed a case-cohort study of 8,604 randomly selected women within a mammography screening cohort initiated in 2010 in Sweden for women age 40-74 years. Mammograms, age, lifestyle, and familial risk factors were collected at study entry. In all, 2,028 incident breast cancers were identified through register matching in May 2022 (206 incident breast cancers were found in the subcohort). The image-based model extracted mammographic features (density, microcalcifications, masses, and left-right breast asymmetries of these features) and age from study entry mammograms. The Tyrer-Cuzick v8 risk model incorporates self-reported lifestyle and familial risk factors and mammographic density to estimate risk. Absolute risks were estimated, and age-adjusted AUC model performances (aAUCs) were compared across the 10-year period. The aAUCs of the image-based risk model ranged from 0.74 (95% CI, 0.70 to 0.78) to 0.65 (95% CI, 0.63 to 0.66) for breast cancers developed 1-10 years after study entry; the corresponding Tyrer-Cuzick aAUCs were 0.62 (95% CI, 0.56 to 0.67) to 0.60 (95% CI, 0.58 to 0.61). For symptomatic cancers, the aAUCs for the image-based model were ≥0.75 during the first 3 years. Women with high and low mammographic density showed similar aAUCs. Throughout the 10-year follow-up, 20% of all women with breast cancers were deemed high-risk at study entry by the image-based risk model compared with 7.1% using the lifestyle familial-based model ( The image-based risk model outperformed the Tyrer-Cuzick v8 model for both short-term and long-term risk assessment and could be used to identify women who may benefit from supplemental screening and risk reduction strategies.
Identifiants
pubmed: 36930854
doi: 10.1200/JCO.22.01564
pmc: PMC10414699
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
2536-2545Références
J Natl Cancer Inst. 2018 Sep 1;110(9):994-1002
pubmed: 29490057
Breast Cancer Res. 2011;13(6):223
pubmed: 22114898
Breast Cancer Res Treat. 2020 Apr;180(2):481-490
pubmed: 32056055
J Med Screen. 2021 Mar;28(1):34-38
pubmed: 32370610
Breast Cancer Res Treat. 2018 Jun;169(2):371-379
pubmed: 29392583
Nature. 2020 Jan;577(7788):89-94
pubmed: 31894144
Cancers (Basel). 2021 Jan 15;13(2):
pubmed: 33467653
Breast Cancer Res Treat. 2014 Apr;144(3):479-502
pubmed: 24615497
J Am Coll Radiol. 2017 Sep;14(9):1137-1143
pubmed: 28648873
AJR Am J Roentgenol. 2021 Jul;217(1):48-55
pubmed: 33978450
J Clin Epidemiol. 1999 Dec;52(12):1165-72
pubmed: 10580779
Int J Equity Health. 2015 Dec 30;14:157
pubmed: 26715453
JAMA. 2019 Sep 3;322(9):857-867
pubmed: 31479144
Cochrane Database Syst Rev. 2019 Apr 29;4:CD012191
pubmed: 31032883
Stat Med. 2004 Apr 15;23(7):1111-30
pubmed: 15057881
Radiology. 2020 Nov;297(2):327-333
pubmed: 32897160
J Clin Oncol. 2020 Nov 20;38(33):3874-3882
pubmed: 32931396
Sci Transl Med. 2022 May 11;14(644):eabn3971
pubmed: 35544593
J Natl Compr Canc Netw. 2015 Jul;13(7):880-915
pubmed: 26150582
Breast Cancer Res. 2022 Feb 20;24(1):14
pubmed: 35184757
N Engl J Med. 2000 Jul 20;343(3):191-8
pubmed: 10900280
BMJ. 1994 Jul 9;309(6947):102
pubmed: 8038641
Biometrika. 2009 Jun;96(2):371-382
pubmed: 22822245
Br J Cancer. 2019 Jul;121(1):76-85
pubmed: 31114019
Breast Cancer Res. 2017 Mar 14;19(1):29
pubmed: 28288659
Eur J Epidemiol. 2017 Sep;32(9):765-773
pubmed: 28983736
Stat Med. 2000 May 15;19(9):1141-64
pubmed: 10797513
Ann Intern Med. 2016 Feb 16;164(4):279-96
pubmed: 26757170
Cancer Epidemiol Biomarkers Prev. 2004 Apr;13(4):501-10
pubmed: 15066912
Eur Radiol. 2014 Sep;24(9):2227-35
pubmed: 24895040
Ann Oncol. 2016 Apr;27(4):575-90
pubmed: 26646754
Sci Transl Med. 2021 Jan 27;13(578):
pubmed: 33504648
Int J Epidemiol. 2017 Dec 1;46(6):1740-1741g
pubmed: 28180256
Ann Intern Med. 2011 Jul 5;155(1):10-20
pubmed: 21727289
CA Cancer J Clin. 2019 May;69(3):184-210
pubmed: 30875085
Am J Epidemiol. 2015 Nov 15;182(10):863-7
pubmed: 26520360
N Engl J Med. 2015 Jun 11;372(24):2353-8
pubmed: 26039523
PLoS One. 2014 Jun 27;9(6):e101176
pubmed: 24972092